Dr. Michael D. Privitera Jr., MD

Dr. Privitera practices at UC Medical Center in Cincinnati, Ohio.

Dr. Privitera's NPI, 1629005814, was assigned on June 26, 2006. Dr. Privitera graduated from State University of New York at Buffalo School of Medicine in 1980. Dr. Privitera holds Ohio license 35054494.

Dr. Privitera's primary practice is UC Medical Center, at 3188 Bellevue Ave, Cincinnati, OH 45219 in Hamilton County. The practice phone is (513) 584-1000.

Dr. Privitera's primary practice is UC Medical Center in Cincinnati, Ohio. Dr. Privitera is also affiliated with University of Cincinnati Medical Center. The medical group on file is University of Cincinnati Physicians. Dmand AI also links Dr. Privitera to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Privitera practices, 6 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Privitera's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Privitera is licensed in Ohio.

CMS data shows 371 Medicare services from Dr. Privitera across 6 procedure codes in 2024, for 163 Medicare patients. Medicare paid $21,177 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 163 Medicare patients who saw Dr. Privitera in 2024. The largest group is under 65, with 60 patients. 67% of them have high cholesterol, and 59% have high blood pressure. 38% are also on Medicaid. Their average risk score is 1.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Privitera's median patient age at 54, with 52% women.

In 2024, Dr. Privitera wrote 4,250 Medicare Part D claims for 274 patients. 77% of them were for generic drugs. CMS names the drug for 4,124 of them, across 63 drugs with 11 or more claims each, at $1,684,310 in total drug cost. In 2023, CMS named 3,986 claims across 62 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Privitera for performance year 2024, reported as part of a group. Dr. Privitera accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Privitera as offering telehealth.

Dmand AI links 62 papers to Dr. Privitera, published from 2010 to 2025. 2021 was the busiest year, with 7. The most frequent topics are Epilepsy, Anticonvulsants and Seizures. Dr. Privitera has published most often in Epilepsy Behav. Dr. Privitera's most frequent co-authors are Jerzy Szaflarski, Sheryl R. Haut, MD and Laura Ann Kalayjian, MD.

CMS Open Payments shows 244 general payments to Dr. Privitera from 11 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 38% of the total. SK Life Science, Inc. paid the most, $131,828. It also lists 4 research payments totaling $179,289 from 2020 to 2022.

Dr. Privitera graduated from State University of New York at Buffalo School of Medicine in 1980.